Privo Technologies Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.21M

  • Investors
  • 9

Privo Technologies General Information

Description

Developer of nano-engineered oncology therapeutics designed for localized cancer treatment. The company's technology utilizes nanotechnology to encapsulate potent therapies within a biodegradable polymeric matrix for direct delivery to tumor sites, enabling patients to receive concentrated chemotherapy while limiting systemic exposure and avoiding surgical intervention.

Contact Information

Website
www.privotechnologies.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 200 Corporate Place
  • Suite 6B
  • Peabody, MA 01960
  • United States
+1 (978)
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Services
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences, Oncology
Corporate Office
  • 200 Corporate Place
  • Suite 6B
  • Peabody, MA 01960
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Privo Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 31-Jan-2024 $5.21M Completed Clinical Trials - Phase 4
11. Grant 25-Feb-2022 Completed Clinical Trials - Phase 4
10. Accelerator/Incubator 22-Feb-2021 Completed Clinical Trials - General
9. Grant 01-Jan-2021 Completed Clinical Trials - General
8. Grant 12-Nov-2018 Completed Clinical Trials - General
7. Grant 01-Jan-2018 Completed Clinical Trials - General
6. Grant 01-Jan-2018 Completed Clinical Trials - General
5. Grant 01-Jan-2016 Completed Startup
4. Grant 01-Jan-2015 $1.06M Completed Startup
3. Grant 01-Jan-2014 $221K Completed Startup
To view Privo Technologies’s complete valuation and funding history, request access »

Privo Technologies Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Privo Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022286943-A1 Enhanced two-stage microparticle-based localized therapeutic delivery system Active 01-Jun-2021
AU-2022286943-B2 Enhanced two-stage microparticle-based localized therapeutic delivery system Active 01-Jun-2021
CA-3220269-A1 Enhanced two-stage microparticle-based localized therapeutic delivery system Pending 01-Jun-2021
EP-4346797-A1 Enhanced two-stage microparticle-based localized therapeutic delivery system Pending 01-Jun-2021
EP-4346797-A4 Enhanced two-stage microparticle-based localized therapeutic delivery system Pending 01-Jun-2021 A61K9/5161
To view Privo Technologies’s complete patent history, request access »

Privo Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Privo Technologies Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
AIM-HI Accelerator/Incubator Minority
MIT Deshpande Center Not-For-Profit Venture Capital
National Cancer Institute Government
National Institute of Dental and Craniofacial Research Government
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Privo Technologies FAQs

  • When was Privo Technologies founded?

    Privo Technologies was founded in 1991.

  • Where is Privo Technologies headquartered?

    Privo Technologies is headquartered in Peabody, MA.

  • What is the size of Privo Technologies?

    Privo Technologies has 10 total employees.

  • What industry is Privo Technologies in?

    Privo Technologies’s primary industry is Drug Delivery.

  • Is Privo Technologies a private or public company?

    Privo Technologies is a Private company.

  • What is Privo Technologies’s current revenue?

    The current revenue for Privo Technologies is .

  • How much funding has Privo Technologies raised over time?

    Privo Technologies has raised $900K.

  • Who are Privo Technologies’s investors?

    National Institutes of Health, AIM-HI, MIT Deshpande Center, National Cancer Institute, and National Institute of Dental and Craniofacial Research are 5 of 9 investors who have invested in Privo Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process